Today: 7 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

Axon Enterprise shares closed at $594.20 on Dec. 19, up 5.4% after announcing early redemption of its 0.50% convertible notes due 2027. The company notified holders they may convert notes until Feb. 6, 2026, with settlement set for Feb. 10. Recent headlines also include new municipal AI-policing contracts and an analyst price-target cut that kept a bullish rating.
20 December 2025
·
BigBear.ai Stock News (BBAI) on Dec. 20, 2025: Border-Security Partnership Sparks Rally as Dilution Vote Looms

BigBear.ai Stock News (BBAI) on Dec. 20, 2025: Border-Security Partnership Sparks Rally as Dilution Vote Looms

BigBear.ai shares jumped 11% Friday to $6.26 after announcing a partnership with C Speed to integrate AI with radar systems for defense and homeland security. Trading volume hit 218 million shares. The company also faces an upcoming shareholder vote that could affect its capital strategy and potential dilution risk. No financial terms were disclosed for the C Speed deal.
20 December 2025
··
Ciena Stock (CIEN) News, Forecasts and Analyst Targets as of Dec. 20, 2025: AI Networking Tailwinds Meet a Stretched Valuation Debate

Ciena Stock (CIEN) News, Forecasts and Analyst Targets as of Dec. 20, 2025: AI Networking Tailwinds Meet a Stretched Valuation Debate

Ciena shares closed at $230.34 on Dec. 19, up 9.32% after reporting fiscal Q4 revenue of $1.352 billion, a 20% jump year over year. The company issued 2026 guidance above expectations, projecting up to $6.1 billion in revenue. Analysts raised price targets, while some questioned valuation. Ciena cited AI and cloud demand as key drivers and reported a record order backlog entering 2026.
20 December 2025
··
Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston Stock (NYSE: LW) Sinks After Earnings: Discounting, Margin Pressure, Dividend Hike, and Fresh 2026 Forecasts (20 Dec 2025)

Lamb Weston shares fell about 20% on December 19 after the company reported fiscal Q2 2026 results that beat expectations but maintained a cautious full-year outlook. The stock closed near $43.94 on December 20. Despite 8% volume growth, price/mix dropped 8%, pressuring margins. Investors focused on the company’s reliance on discounting and muted demand signals.
20 December 2025
···
Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group N.V. (NBIS) Stock News: Blackwell Ultra Launch, Microsoft & Meta Deals, and Wall Street Forecasts (Dec. 20, 2025)

Nebius Group shares surged 14.6% to $89.46 Friday, Dec. 19, on heavy trading after launching its AI Cloud 3.1 platform with NVIDIA Blackwell Ultra compute. The Amsterdam-based company, formerly Yandex, has become a key AI infrastructure stock, competing with Amazon and Google. Investors remain focused on Nebius’s rapid expansion and spending to meet AI demand.
20 December 2025
··
Moderna Stock (MRNA) News, Forecasts and Analysis: CEPI Bird Flu Funding, FDA Scrutiny and the 2026 Outlook (Dec. 20, 2025)

Moderna Stock (MRNA) News, Forecasts and Analysis: CEPI Bird Flu Funding, FDA Scrutiny and the 2026 Outlook (Dec. 20, 2025)

Moderna shares rose about 9% to $33.80 after the company secured up to $54.3 million from CEPI for a Phase 3 trial of its H5 bird flu vaccine. The funding follows a canceled U.S. government contract earlier this year. Meanwhile, U.S. regulators are reviewing possible COVID-19 vaccine safety issues, with conflicting reports on potential FDA warnings.
20 December 2025
·
Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic shares rose 6.71% to $3.50 on Friday, capping a four-day rally after the company repurchased $354.6 million of its 2027 convertible notes and issued new debt and equity. Trading volume hit 7.9 million, well above average. The stock remains 48% below its 52-week high. Virgin Galactic also announced a high-altitude imaging deal with Lawrence Livermore National Laboratory.
20 December 2025
··
Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab shares closed at a record $70.52 Friday, up 17.7%, after announcing its largest contract to date: an $805 million U.S. Space Force award to build 18 missile-tracking satellites. The deal is part of a $3.5 billion Space Development Agency program with launches targeted by 2029.
20 December 2025
····
Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies stock closed at $0.6044 on December 19, 2025, amid heavy trading after the company filed for Chapter 11 bankruptcy on December 15. Nasdaq delisting is imminent. Luminar warned that stock prices during bankruptcy may not reflect eventual shareholder outcomes. Over 90% of first-lien and 85% of second-lien noteholders back the restructuring plan.
20 December 2025
·
National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid shares closed at 1,142p on 19 December 2025, up nearly 24% over the past year, with a dividend yield near 4.1%. Investors are watching Ofgem’s RIIO-T3 final determination, which sets a 6.12% allowed cost of equity from April 2026. National Grid expects to respond to licence terms in early March 2026. The company’s market cap stands at about £56.6 billion.
20 December 2025
·
Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Fitch reaffirmed Imperial Brands’ ‘BBB’ rating with a Stable outlook, citing strong cash flow from tobacco and disciplined capital allocation. The company continued its £1.45 billion share buyback, purchasing over 388,000 shares on Dec. 18–19 at around 3,182p each. Fitch expects cigarettes to remain over 90% of revenue by 2028, with NGP at 4.4% in FY25. A $400 million litigation payment is projected for 2026.
20 December 2025
·
Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

Rio Tinto shares closed Friday at 5,838p in London, up 4.46% for the week, and $78.33 in New York. The company’s new CEO, Simon Trott, unveiled a strategy overhaul with upgraded copper and bauxite guidance, lower copper unit costs, and plans for asset sales or partnerships. Analysts noted a push for productivity gains, cost cuts, and up to $10 billion in divestments.
20 December 2025
···
Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

Standard Chartered shares closed at 1,788.50p on December 20, near a 52-week high and up roughly 80%–90% year-to-date. The bank disclosed buying 535,961 shares on December 18 as part of a buyback program, with nearly US$984 million spent so far. German regulators have ordered action at the bank’s local unit, and Indian authorities are probing alleged client fund diversion.
20 December 2025
·
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK agreed to a U.S. drug-pricing deal covering its respiratory portfolio, securing a three-year exemption from tariffs and pledging lower Medicaid prices and direct-to-consumer discounts. The company also received fresh FDA approval for a severe asthma drug and expanded vaccine indications in Europe. GSK’s ADR closed Friday, Dec. 19, at $48.61.
20 December 2025
···
Shell Plc Stock (SHEL) News, Forecasts and Analysis for Dec. 20, 2025: Buybacks, LNG Outlook and Project Pipeline Drive the Narrative

Shell Plc Stock (SHEL) News, Forecasts and Analysis for Dec. 20, 2025: Buybacks, LNG Outlook and Project Pipeline Drive the Narrative

Shell shares closed at £27.03 in London on Dec. 19, up 1.54%, with trading volume above recent averages. The company repurchased nearly 2 million shares that day across London and Amsterdam as part of its $3.5 billion buyback program. Shell’s NYSE ADR stood at $72.02, near the top of its annual range. Investors continue to weigh strong capital returns against long-term production and legal risks.
20 December 2025
··
HSBC Holdings Plc Stock: Hang Seng Buyout Momentum, Analyst Upgrades, and the 2026 Outlook (Dec. 20, 2025)

HSBC Holdings Plc Stock: Hang Seng Buyout Momentum, Analyst Upgrades, and the 2026 Outlook (Dec. 20, 2025)

HSBC and Hang Seng Bank have dispatched the scheme document for HSBC’s proposed HK$13.6 billion take-private of Hang Seng, offering HK$155 per share—a 33% premium. Court and shareholder meetings are set for January 8, with delisting expected January 27 if approved. HSBC shares traded at 1,167p in London, HK$119.30 in Hong Kong, and $77.92 in New York as of late December 19.
20 December 2025
···
1 … 415 416 417 418 419 … 588

Stock Market Today

  • Why Americas Gold and Silver Shares Drop 19.7% Despite High-Grade Cosalá Drill Results
    June 6, 2026, 6:16 PM EDT. Americas Gold and Silver (TSX:USA) shares fell 19.7% following the announcement of infill drill results at its Cosalá Complex, which revealed silver grades up to five times higher than the current resource model. The company is conducting its largest drilling program through 2026, aiming to revise its mine plan and reserves to reflect these findings. Despite the promising grades, the stock decline reflects investor concerns over recent dilution, insider selling, a new management team, and execution risks across its Cosalá, Galena, and Crescent projects. The shares currently trade below some fair value estimates ranging from US$12.29 to US$33.60, highlighting divergent views on the company's prospects. Key near-term catalysts include reserve updates, 2026 production guidance, and Crescent's timely restart without additional financial strain.

Latest articles

Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

7 June 2026
Strategy’s surprise sale of 32 Bitcoin for $2.5 million to fund preferred stock distributions rattled investors, raising fears it may sell more to meet obligations, as Bitcoin and Ether posted their worst weekly losses since 2022 and crypto-linked stocks like Coinbase and Robinhood plunged up to 11% amid a $390 billion market wipeout.
Bitcoin Hits $60,000 As Crypto Selloff Deepens

Bitcoin Drops as ETF Outflows Mount, $60,000 Support Weakens

7 June 2026
Bitcoin plunged below $60,000 for the first time since October 2024, triggering $4.4 billion in spot ETF outflows and a rare bitcoin sale by Strategy, while crypto-linked stocks tumbled and analysts warned that further drops below $59,750 could spark more selling pressure or a deeper slide.
Johnson & Johnson Shares Hold Up in Market Selloff — Looking at What May Shift JNJ Next Week

Johnson & Johnson Shares Hold Up in Market Selloff — Looking at What May Shift JNJ Next Week

6 June 2026
Johnson & Johnson jumped 2.02% to $232.77 Friday—outperforming a plunging S&P 500—after a Los Angeles jury found the company not negligent in a talc cancer lawsuit; investors now eye next week’s Goldman Sachs healthcare conference and a fresh $1.34 dividend, as J&J touts new drug launches and raised its 2026 outlook despite ongoing litigation and Stelara sales declines.
Eli Lilly Stock Sets High Ahead of Monday Data

Eli Lilly Stock Sets High Ahead of Monday Data

6 June 2026
Eli Lilly shares hit a record $1,131.42 close Friday, up 0.6%, after late-stage data showed its experimental retatrutide cut sleep apnea severity by 60.6% and knee osteoarthritis pain by up to 73.1% in obese adults; investors will watch Monday’s trade to see if the new results justify Lilly’s premium as the S&P 500 tumbled 2.64% Friday and rivals like Roche posted strong obesity-drug data.
Go toTop